$10.85
+0.02 (+0.18%)
Open$11.14
Previous Close$10.83
Day High$11.23
Day Low$10.80
52W High$22.55
52W Low$9.37
Volume—
Avg Volume150.2K
Market Cap193.32M
P/E Ratio—
EPS$-3.70
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+81.6% upside
Current
$10.85
$10.85
Target
$19.70
$19.70
$13.49
$19.70 avg
$20.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 114.86M | 4.38M | 103.26M |
| Net Income | 40.95M | -207,966,613 | -15,524,708 |
| Profit Margin | 35.7% | -5,013.7% | -15.0% |
| EBITDA | 32.51M | -245,260,567 | -22,220,211 |
| Free Cash Flow | — | — | -17,331,210 |
| Rev Growth | — | -43.9% | +11.8% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |